1. Home
  2. TECH vs MBLY Comparison

TECH vs MBLY Comparison

Compare TECH & MBLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$51.74

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Logo Mobileye Global Inc.

MBLY

Mobileye Global Inc.

HOLD

Current Price

$9.46

Market Cap

9.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECH
MBLY
Founded
1976
1999
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
9.1B
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
TECH
MBLY
Price
$51.74
$9.46
Analyst Decision
Strong Buy
Buy
Analyst Count
11
20
Target Price
$71.82
$14.13
AVG Volume (30 Days)
2.8M
6.0M
Earning Date
05-06-2026
04-23-2026
Dividend Yield
0.62%
N/A
EPS Growth
N/A
87.43
EPS
0.81
N/A
Revenue
$1,219,635,000.00
$1,894,000,000.00
Revenue This Year
$2.49
$4.91
Revenue Next Year
$6.40
$13.94
P/E Ratio
$65.60
N/A
Revenue Growth
5.23
14.51
52 Week Low
$43.20
$6.47
52 Week High
$72.16
$20.18

Technical Indicators

Market Signals
Indicator
TECH
MBLY
Relative Strength Index (RSI) 54.01 44.70
Support Level $49.98 $8.43
Resistance Level $57.86 $9.62
Average True Range (ATR) 1.88 0.56
MACD 0.81 -0.08
Stochastic Oscillator 84.03 7.80

Price Performance

Historical Comparison
TECH
MBLY

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About MBLY Mobileye Global Inc.

Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. The company's reportable operating segment are Mobileye and Moovit. The solutions provided by the company are: Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It derives maximum revenue from Mobileye Segment.

Share on Social Networks: